Product approvals

Explore the landscape of product approvals in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on product approvals to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Danatlas Pharmaceuticals Wins NMPA IND Approval for DAT‑6618 – China's First PPARγ Inhibitor to Enter Clinical Development
CompanyDrug

Danatlas Pharmaceuticals Wins NMPA IND Approval for DAT‑6618 – China’s First PPARγ Inhibitor to Enter Clinical Development

Danatlas Pharmaceuticals announced that the Investigational New Drug (IND) application for DAT‑6618, an independently developed PPARγ inhibitor, has been approved by China's National Medical Products Administration (NMPA). DAT‑6618 is the…

Ribo Life Science Opens Automated Intelligent Drug Screening Center – A Key Leap in AI‑Powered siRNA Drug Discovery

Ribo Life Science Opens Automated Intelligent Drug Screening Center – A Key Leap in AI‑Powered siRNA Drug Discovery

CSPC to Unveil Data From 8 Oncology Trials at ESMO Congress 2026 – Anbenitamab Phase III Results Headline Two Late‑Breaking Abstracts

CSPC to Unveil Data From 8 Oncology Trials at ESMO Congress 2026 – Anbenitamab Phase III Results Headline Two Late‑Breaking Abstracts

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Shanghai Sanyou Medical Receives NMPA Marketing License for JAZZ Spinal Fixation System
CompanyMedical Device

Shanghai Sanyou Medical Receives NMPA Marketing License for JAZZ Spinal Fixation System

Vigonvita's Simenafil Receives NMPA Approval for Erectile Dysfunction Treatment
CompanyDrug

Vigonvita’s Simenafil Receives NMPA Approval for Erectile Dysfunction Treatment

Bayer AG's Kerendia Approved by FDA to Treat Adult Heart Failure with Ejection Fraction ≥40%
CompanyDrug

Bayer AG’s Kerendia Approved by FDA to Treat Adult Heart Failure with Ejection Fraction ≥40%

Bayer's Elinzanetant Granted UK Marketing Authorization for Menopause-Related Vasomotor Symptoms
CompanyDrug

Bayer’s Elinzanetant Granted UK Marketing Authorization for Menopause-Related Vasomotor Symptoms

BeOne Medicines' Tevimbra Approved by European Commission for Nasopharyngeal Carcinoma
CompanyDrug

BeOne Medicines’ Tevimbra Approved by European Commission for Nasopharyngeal Carcinoma

Johnson & Johnson MedTech Launches VARIPULSE Platform for Atrial Fibrillation in Asia-Pacific
CompanyMedical Device

Johnson & Johnson MedTech Launches VARIPULSE Platform for Atrial Fibrillation in Asia-Pacific

Zelgen's ZG006 Receives Breakthrough Therapy Designation for Advanced Small Cell Lung Cancer
CompanyDrug

Zelgen’s ZG006 Receives Breakthrough Therapy Designation for Advanced Small Cell Lung Cancer

Ascentage Pharma's Lisaftoclax Receives NMPA Approval for CLL/SLL Treatment
CompanyDrug

Ascentage Pharma’s Lisaftoclax Receives NMPA Approval for CLL/SLL Treatment

Show More